Neurocrine Biosciences Inc (NAS:NBIX)
$ 136.53 -0.46 (-0.34%) Market Cap: 13.82 Bil Enterprise Value: 12.85 Bil PE Ratio: 36.60 PB Ratio: 5.08 GF Score: 88/100

Neurocrine Biosciences Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 03:55PM GMT
Release Date Price: $83.25 (-1.76%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI Biotech team. Very pleased to welcome -- we have Matt Abernethy and Eiry Roberts from Neurocrine.

Questions & Answers

Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

A lot going on and a lot recently going on. I have to admit, I don't know a lot about M4 selective agonist in enrolling schizophrenia, but that seemed to be part of the basis for this new collaboration with Sosei. So just give a little bit of a backdrop of this collaboration? And what's exciting about the M4 selective agonist approach.

Matthew C. Abernethy
Neurocrine Biosciences, Inc. - CFO

Sure, Josh. Thanks for welcoming Eiry and I. Really appreciate you hosting us this year. And hope we can be in Boston next year, that would be very nice. We will be making forward-looking statements so we'd

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot